Bolt Biotherapeutics, Inc. (BOLT)
NASDAQ: BOLT · Real-Time Price · USD
4.380
-0.120 (-2.67%)
Mar 27, 2026, 4:00 PM EDT - Market closed
Bolt Biotherapeutics Market Cap
Bolt Biotherapeutics has a market cap or net worth of $8.42 million as of March 27, 2026. Its market cap has decreased by -47.48% in one year.
Market Cap
8.42M
Enterprise Value
4.17M
1-Year Change
-47.48%
Ranking
Category
Stock Price
$4.38
Market Cap Chart
Since the IPO on February 5, 2021, Bolt Biotherapeutics's market cap has decreased from $690.43M to $8.42M, a decrease of -98.78%. That is a compound annual growth rate of -57.58%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 27, 2026 | 8.42M | -19.81% |
| Dec 31, 2025 | 10.50M | -48.75% |
| Dec 31, 2024 | 20.48M | -51.84% |
| Dec 29, 2023 | 42.52M | -13.15% |
| Dec 30, 2022 | 48.96M | -73.20% |
| Dec 31, 2021 | 182.69M | -73.54% |
| Feb 5, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CollPlant Biotechnologies | 9.58M |
| BioAtla | 9.30M |
| SeaStar Medical Holding | 9.11M |
| Iterum Therapeutics | 9.08M |
| CalciMedica | 9.07M |
| Imunon | 8.54M |
| PharmaCyte Biotech | 8.17M |
| Kiora Pharmaceuticals | 8.06M |